The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 03, 2017
Filed:
Jun. 06, 2014
Applicant:
Wellesley Pharmaceuticals, Llc, Newtown, PA (US);
Inventors:
David A. Dill, Newtown, PA (US);
Frank J. Rauscher, III, Wayne, PA (US);
Assignee:
WELLESLEY PHARMACEUTICALS, LLC, Newtown, PA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/167 (2006.01); A61K 31/44 (2006.01); C07K 16/28 (2006.01); A61K 31/713 (2006.01); A61K 31/192 (2006.01); A61K 31/27 (2006.01); A61K 31/437 (2006.01); A61K 31/616 (2006.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61K 31/27 (2013.01); A61K 31/437 (2013.01); A61K 31/616 (2013.01);
Abstract
Methods and compositions for reducing frequency of urination are disclosed. The methods comprise administering to a subject having a condition that resulting in undesired frequency of urination an effective amount of a pharmaceutical composition comprising one or more prostaglandin pathway inhibitors. The pharmaceutical compositions comprise one or more prostaglandin pathway inhibitors and a pharmaceutically acceptable carrier.